JMIR Medical Informatics
Clinical informatics, decision support for health professionals, electronic health records, and eHealth infrastructures.
Editor-in-Chief:
Arriel Benis, PhD, FIAHSI, Associate Professor and Head of the Department of Digital Medical Technologies, Holon Institute of Technology (HIT), Israel
Impact Factor 3.8 CiteScore 7.7
Recent Articles

General anesthesia comprises three essential components—hypnosis, analgesia, and immobility. Among these, maintaining an appropriate hypnotic state, or anesthetic depth, is crucial for patient safety. Excessively deep anesthesia may lead to hemodynamic instability and postoperative cognitive dysfunction, whereas inadequate anesthesia increases the risk of intraoperative awareness. Electroencephalography (EEG)–based monitoring has therefore become a cornerstone for evaluating anesthetic depth. However, processed EEG (pEEG) indices remain vulnerable to various sources of interference, including electromyographic activity, interindividual variability, and anesthetic drug effects, which can yield inaccurate numerical outputs.

AI scribes, software that can convert speech into concise clinical documents, have achieved remarkable clinical adoption at a pace rarely seen for digital technologies in healthcare. The reasons for this are understandable: the technology works well enough, it addresses a genuine pain point for clinicians, and it has largely sidestepped regulatory requirements. In many ways, clinical adoption of AI scribes has also occurred well ahead of robust evidence of their safety and efficacy. The papers in this theme issue demonstrate real progress in the technology and evidence of its benefit: documentation times are reported to decrease when using scribes, clinicians report feeling less burdened, and the notes produced are often of reasonable quality. Yet as we survey the emerging evidence base, there remains one outstanding and urgent unanswered question: Are AI scribes safe? We need to know the clinical outcomes achievable when scribes are used compared to other forms of note taking.

Harmful suicide content on the internet poses significant risks, as it can induce suicidal thoughts and behaviors, particularly among vulnerable populations. Despite global efforts, existing moderation approaches remain insufficient, especially in high-risk regions like South Korea, which has the highest suicide rate among OECD countries. Previous research has primarily focused on assessing the suicide risk of the authors who wrote the content rather than the harmfulness of content itself which potentially leads the readers to self-harm or suicide, highlighting a critical gap in current approaches. Our study addresses this gap by shifting the focus from assessing the suicide risk of content authors to evaluating the harmfulness of the content itself and its potential to induce suicide risk among readers.

Data linkage in pharmacoepidemiological research is commonly employed to ascertain exposure and outcomes, or to obtain more information about confounding variables. However, to protect patient confidentiality usually unique patient identifiers are not provided; thus, makes data linkage between various sources challenging. The Saudi Real-Evidence Researches Network (RERN) aggregates Electronic Health Records from various hospitals, which may require a robust linkage technique.

The Cox proportional hazards (CPH) model is a common choice for analyzing time to treatment interruptions in patients on antiretroviral therapy (ART), valued for its straightforward interpretability and flexibility in handling time-dependent covariates. Machine learning (ML) models have increasingly been adapted for handling temporal data, with added advantages of handling complex, non-linear relationships, large datasets, and provide clear practical interpretations.



We used the free artificial intelligence (AI) tool Google NotebookLM, powered by the large language model Gemini 2.0, to construct a medical decision-making aid for diagnosing and managing airway diseases and subsequently evaluated its functionality and performance in a clinical workflow. After feeding this tool with relevant published clinical guidelines for these diseases, we evaluated the feasibility of the system regarding its behavior, ability, and potential, and we created simulated cases and used the system to solve associated medical problems. The test and simulation questions were designed by a pulmonologist, and the appropriateness (focusing on accuracy and completeness) of AI responses was judged by 3 pulmonologists independently. The system was then deployed in an emergency department setting, where it was tested by medical staff (n=20) to assess how it affected the process of clinical consultation. Test opinions were collected through a questionnaire. Most (56/84, 67%) of the specialists’ ratings regarding AI responses were above average. The interrater reliability was moderate for accuracy (intraclass correlation coefficient=0.612; P<.001) and good on completeness (intraclass correlation coefficient=0.773; P<.001). When deployed in an emergency department (ED) setting, this system could respond with reasonable answers, enhance the literacy of personnel about these diseases. The potential to save the time spent in consultation did not reach statistical significance (Kolmogorov-Smirnov [K-S] D=0.223, P=.24) across all participants, but it indicated a favorable outcome when we analyzed only physicians’ responses. We concluded that this system is customizable, cost efficient, and accessible to clinicians and allied health care professionals without any computer coding experience in treating airway diseases. It provides convincing guideline-based recommendations, increases the staff’s medical literacy, and potentially saves physicians’ time spent on consultation. This system warrants further evaluation in other medical disciplines and health care environments.

A rapidly aging population led to an increase in the number of patients with chronic diseases and polypharmacy. Although investigations on the appropriate number of drugs for older patients have been conducted, there is a shortage of studies on polypharmacy criteria in older inpatients from multiple institutions.
Preprints Open for Peer Review
Open Peer Review Period:
-
Open Peer Review Period:
-
Open Peer Review Period:
-
Open Peer Review Period:
-
Open Peer Review Period:
-
Open Peer Review Period:
-









